Report for the first quarter of 2023
Oslo, 30 May 2023
Highlights in the period
- Gross production in Q1 2023 decreased 21% compared to Q4 2022.
- In January 2023, the Company timely paid accrued and due interest on its corporate bond.
- Early in February 2023, the Company was notified of the formal approval to its acquisition of the 8.34% participating interests in five concessions in Santa Cruz, Argentina where the Company also serves as operator.
- The Company has worked with the relevant Provincial authorities on the satisfaction of the requirements to restart full activities in the MMO and Cañadón Ramírez fields (Chubut, Argentina) and reopened such fields.
For more information, please see enclosed Interoil Exploration and Production ASA's Report for the first quarter of 2023.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
***************************
Please direct any further questions to ir@interoil.no (mailto:ir@interoil.no)
About Interoil
Interoil Exploration and Production ASA is a Norwegian based exploration and production company - listed on the Oslo Stock Exchange with focus on Latin America. The Company is operator and license holder of several production and exploration assets in Colombia and Argentina with headquarter in Oslo.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Standard Lithium Strengthens C-Suite: Salah Gamoudi Appointed CFO, Kara Norman Steps Into New Role as CAO25.9.2023 12:01:09 CEST | Press release
VANCOUVER, British Columbia, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium company, today announced an enhanced C-suite with the addition of Salah Gamoudi as Chief Financial Officer, effective October 1, 2023. This decision aligns with the Company's efforts to bolster its senior leadership as it prepares for a dynamic phase of growth. Robert Mintak, CEO and Director of Standard Lithium, stated, “As we place greater emphasis on commercial construction, resource expansion, and strategic partnerships, Salah's addition is timely. Kara Norman's leadership as CFO, especially during our early growth and the NYSE American listing, has been foundational. With Salah joining as CFO and Kara transitioning to the Chief Accounting Officer role, we're strategically positioning our leadership for the Company's next chapter.” Salah Gamoudi commented, “Joining Standard Lithium at
Concentrix and Webhelp Complete Combination, Creating a Diversified Global CX Leader, Well-Positioned for Growth25.9.2023 12:00:00 CEST | Press release
NEWARK, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC), a leading global provider of customer experience (CX) services and technologies, today announced it has closed its combination with Webhelp and the integration of the two companies is underway. While the combined company finalizes its permanent name, it will operate under the trade name Concentrix + Webhelp. This combination further positions Concentrix + Webhelp as a global CX leader, with an expanded breadth of generative AI solutions, digital capabilities, and high-value services. It also strengthens its end-to-end CX value proposition, with one of the most robust, well-balanced global footprints in the industry to help the world’s best brands transform customer experiences and achieve their business goals. “I am excited to embark on this new journey together and believe that, with our combined strengths, we are uniquely positioned to redefine the industry and design, build and run the future o
eGain Launches AssistGPT™, First-of-Its-Kind Solution to Automate Knowledge for Customer Engagement25.9.2023 12:00:00 CEST | Press release
SUNNYVALE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- eGain Corporation (NASDAQ: EGAN), the leading knowledge management platform provider for customer engagement automation, launched eGain AssistGPT™ at its Solve™ 23 conference, being held on September 25, at the Brewery, London. An integral part of the eGain Knowledge Hub and powered by Generative AI out of the box, AssistGPT is a comprehensive zero-code solution for Knowledge Automation. For example, knowledge content draft creation, which used to take weeks, can now be completed in just a few minutes. The solution also helps customers in their omnichannel journeys with quick answers and contact center agents and business analysts in the flow of their work. An AI Console allows administrators to define guard rails for the use of generative AI, manage prompts, and orchestrate it with other AI technologies in the enterprise. AssistGPT comes with a best practice prompt library, which enables organizations to add business-specific promp
EPKINLYTM (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare as the First Bispecific Antibody to Treat Adults Patients with Certain Types of Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)25.9.2023 11:55:00 CEST | Press release
Media Release Subcutaneous EPKINLYTM(epcoritamab) is the first and only bispecific antibody approved in Japan to treat adult patients with certain types of relapsed/refractory (R/R) large B-cell lymphoma (LBCL) after two or more lines of systemic therapyApproval based on results of EPCORETM NHL-3 and EPCORETM NHL-1 clinical trials, evaluating EPKINLYin patients with certain types of R/RLBCLLBCLis a common form of non-Hodgkin’s lymphoma (NHL) and currently has limited treatment options, particularly in the R/R setting COPENHAGEN, Denmark; September 25, 2023 – Genmab A/S (Nasdaq:GMAB) announcedtoday that the Japan Ministry of Health, Labour and Welfare has approved EPKINLYTM (epcoritamab) as the first and only T-cell engaging bispecific antibody treatment in Japan of adult patients with certain types of relapsed or refractory large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma (HGBCL), primary mediastinal large B-cell lymphoma (PMBCL)
Wolters Kluwer identifies ESG reporting challenges, demonstrates how technology brings clarity and competitive advantage25.9.2023 11:01:56 CEST | Press release
PRESS RELEASE Wolters Kluweridentifies ESG reporting challenges,demonstrates howtechnology brings clarity and competitive advantage Wolters Kluwer’s Corporate Performance and ESG divisionpoised to play leading role in enabling businesses to navigate emerging ESG reporting challenges LONDON – September 25, 2023– Wolters Kluwer’s Corporate Performance & ESG (CP & ESG) division has set out key issues major corporate and financial services institutions should consider when tackling emerging ESG reporting challenges. The insights are featured in a new white paper, “Bringing clarity to the complexity of financial and ESG reporting,” which zeroes in on the significant impact that the expected enforcement of global ESG regulations will have on multinational companies. The paper, authored by Wolters Kluwer CP & ESG experts, recommends that companies work quickly to leverage technology to bring clarity to the myriad of ESG expectations they face, by transforming the way they collect, report, ana